Capital Markets Day 2026
Schedule a CallCapital Markets Day Video 2026 Highlights
hVIVO Capital Markets Day 2026: Evolving into an Integrated Clinical Development Partner
Recorded live in Canary Wharf on 11 June 2026, our Capital Markets Day outlines hVIVO’s strategic evolution from the world leader in human challenge trials into a full-service, end-to-end early clinical development partner. Watch leadership, industry experts, and partners from Boehringer Ingelheim, RA Capital, ILiAD Biotechnologies, and Decoy Therapeutics discuss how our unified platform accelerates drug development timelines and reduces execution risk from preclinical strategy through to Phase II and III trials.
Watch the Full Sessions
Go deeper into the day with the full talks from our speakers. Hear from King’s Centre for Lung Health on the growing opportunity in respiratory medicine, RA Capital on why investors value human challenge data, Cidara on taking CD388 from challenge study to Phase 3, and a panel with Decoy Therapeutics and Boehringer Ingelheim on what they look for in a clinical partner.
Investor Quick Links
Contact our Investor Relations team.
